(Reuters) – A panel of Indian experts is investigating if there are any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in the country, financial daily Mint reported on Friday.
India is currently administering AstraZeneca’s COVID-19 vaccine and a shot developed at home by Bharat Biotech. (https://bit.ly/2OAP4wc)
Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination.
(Reporting by Juby Babu in Bengaluru; Editing by Shounak Dasgupta)
